Cellectis

French biopharmaceutical company

📊 Rating

2 news mentions · 👍 0 likes · 👎 0 dislikes

📌 Topics

Earnings Report (1)
Biotechnology Finance (1)
Biotechnology (1)
Financial Markets (1)
Healthcare Innovation (1)

🏷️ Keywords

Cellectis (2) · earnings beat (1) · revenue (1) · estimates (1) · financial results (1) · biotech (1) · quarterly report (1) · Jefferies (1) · Buy rating (1) · Stock coverage (1) · Gene editing (1) · CAR-T therapy (1) · Biotechnology investment (1) · Market analysis (1)

📖 Key Information

Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.

📰 Related News (2)

🇺🇸 Cellectis earnings beat by $0.10, revenue topped estimates (2026-03-20)
🇺🇸 Jefferies assumes coverage on Cellectis stock with Buy rating (2026-02-17)

🔗 Entity Intersection Graph

People and organizations frequently mentioned alongside Cellectis:

🌐
Jefferies · 1 shared articles
🌐
Gene editing · 1 shared articles